About Kenneth Greenberg
Kenneth Greenberg, PhD, co-founded SonoThera and is its president and CEO. He previously led external innovation in cell and gene therapy at Janssen and co-founded CODA Biotherapeutics and Oncorus.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Kenneth Greenberg in the role, so the role may have started earlier or lasted longer.
SonoThera, Inc. Current
Co-founder, President and CEO
Director
2022 – Present · South San Francisco, CA
SonoThera develops nonviral genetic medicines that use ultrasound and imaging microbubbles to deliver DNA and RNA into chosen organs, starting with Duchenne muscular dystrophy.
JJ
Janssen (Johnson & Johnson)
UB
UNITY Biotechnology
CB
CODA Biotherapeutics
Co-founder
ON
Oncorus
Co-founder
Education
- PhD, Visual Neuroscience, University of California, Berkeley
- Postdoctoral fellowship (Kirschstein-NRSA), MCB Neurobiology, University of California, Berkeley
Key Colleagues at Startups
The people Kenneth Greenberg works with at each company, as listed on that company's latest Form D.
SonoThera, Inc. · Form D, Jun 30, 2026
SF
Steven Feinstein
Co-founder & Chief Scientific Officer
MD
Michael Davidson
Co-founder & Executive Chairman
RJ
Rajul Jain
Director
SG
Steven Gillis
Director
Rakhshita Dhar
Director
CZ
Carolyne Zimmermann
Chief Business Officer
BH
Brian Halak
Director